Advances in Electron Microscopy Reveal Secrets of HIV and Other Viruses
November 17th 2014UC Davis researchers are getting a new look at the workings of HIV and other viruses thanks to new techniques in electron microscopy developed on campus. The envelope (or Env) protein of HIV is a key target for vaccine makers: it is a key component in RV144, an experimental vaccine that is so far the only candidate to show promise in clinical trials. Also called gp120, the Env protein associates with another protein called gp41 and three gp120/gp41 units associate to form the final trimeric structure. The gp120 trimer is the machine that allows HIV to enter and attack host cells.
European Clinician Consensus Report Provides Recommendations for Improved Management of CDI
November 17th 2014A first-of-its-kind expert consensus report on Clostridium difficile infection (CDI), contributed to by more than 1,000 healthcare professionals across Europe, has been presented today at the Healthcare Infection Society (HIS) International Congress in Lyon, France. The consensus report aimed to identify a set of expert views on CDI management, in order to determine attitudes to diagnosis, treatment and outcomes of CDI and to identify perceived unmet clinical needs.
Scientist Says Electron-Beam Technology May Be a Better Way to Sanitize Ebola Waste
November 14th 2014Dr. Suresh D. Pillai doesn’t want to sensationalize the use of electron beam technology by solely talking about using it to sanitize Ebola virus-contaminated waste. However, he says, it could be much safer and more cost effective than methods used now.